Replies to post #757148 on NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

flipper44,

All the “they could haves” in the world only demonstrate the appeal to ignorance and frustration desired by these guys to achieve their goals. Investor082 puts a bear sign on his posts but admits he expects the price to rise from where we are at by around double in the near future. Kind of hypocritical thinking but works for those desiring to buy cheap de risked shares if following his investment advice to sell the expected spike especially in light of the fact that another poster suggested the price is being kept in check so that some institutions can get in under the radar at the beginning of a new quarter in expectation of good news. Such is the nature of this kind of investing until the rules get changed. Best wishes.

[Investor082]

Nope. I explained to you how it works. It’s up to NWBO to accept NICE rate, whether its $70k, 100k, or whatever it may be around that range. Whether it costs NWBO $50k to manufacture using manual method or $25k using Flaskworks only impacts their profit margin. But the 10X increase in volume that reimbursement approval brings will more than offset the lower margins until Flaskworks catches up.

They are waiting on more clinical evidence in the form of data rather than Flaskworks for NICE submission. This is one of the many reasons LP will be facing a lawsuit for their unethical behavior.

By the way, how would you describe LG’s behavior & statement from 4.5 years ago? You think patients and their families would trust him?